0000935836-19-000538.txt : 20191009 0000935836-19-000538.hdr.sgml : 20191009 20191009151038 ACCESSION NUMBER: 0000935836-19-000538 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20191009 DATE AS OF CHANGE: 20191009 EFFECTIVENESS DATE: 20191009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EcoR1 Venture Opportunity Fund, LP CENTRAL INDEX KEY: 0001778011 IRS NUMBER: 833921119 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-340587 FILM NUMBER: 191144385 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET #3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415-448-6534 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET #3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D/A 1 primary_doc.xml X0708 D/A LIVE 0001778011 EcoR1 Venture Opportunity Fund, LP 357 TEHAMA STREET #3 SAN FRANCISCO CA CALIFORNIA 94103 (415) 754-3517 DELAWARE None None Limited Partnership true 2019 N/A Biotech Opportunity GP, LLC 1370 Trancas Street, Suite 176 Napa CA CALIFORNIA 94558 Executive Officer General Partner Oleg Nodelman 1370 Trancas Street, Suite 176 Napa CA CALIFORNIA 94558 Executive Officer Manager of Biotech Opportunity GP, LLC, General Partner Sarah Marriott 1370 Trancas Street, Suite 176 Napa CA CALIFORNIA 94558 Executive Officer Chief Operating Officer of Biotech Opportunity GP, LLC, General Partner Scott Perlen 1370 Trancas Street, Suite 176 Napa CA CALIFORNIA 94558 Executive Officer Chief Financial Officer of Biotech Opportunity GP, LLC, General Partner Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 true 0000935836-19-000325 2019-06-10 true true true Limited Partner Interests false 2000000 Indefinite 78440000 Indefinite false 48 0 true 0 true 0 true None, although the general partner of the issuer and its investment adviser will receive investment management fees and carried interest distributions. false EcoR1 Venture Opportunity Fund, LP Sarah Marriott Sarah Marriott Chief Operating Officer of Biotech Opportunity GP, LLC, GP 2019-10-09